SPOTLIGHT -
Slideshow
Author(s):
Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.
The Week in Review: February 17-21
Treating ‘Morally Objectionable’ Patients
What Went Wrong? Top 6 Clinical Disappointments
What Will the Future of Alzheimer Disease Treatment Look Like?
Conference Recap: 30th Annual Nevada Psychiatric Association National Psychopharmacology Update
Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia